Michael Desvigne, MD
Plastic and Reconstructive Surgery · Glendale, AZNPI 1356336317
Payments from drug & device makers
Across 1,409 payments — averaging $1573.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$1.1M
- KCI USA, Inc.$592K
- Solventum Corporation$247K
- Smith+Nephew$176K
- Urgo Medical North America, LLC$55K
- Aroa Biosurgery Incorporated$23K
- plus $19K from 29 others
Across 1 payment — averaging $35,120 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Musculoskeletal Transplant Foundation Inc.$35K
What the payments were for
- Consulting fees$1,247,41957%
- Speaking & faculty fees$626,05928%
- Travel & lodging$260,02212%
- Food & beverage$52,4592%
- Education$15,0731%
- Entertainment$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 451 | $1,106,205 |
| KCI USA, Inc. | 440 | $591,957 |
| Solventum Corporation | 145 | $246,552 |
| Smith+Nephew | 239 | $176,062 |
| Urgo Medical North America, LLC | 31 | $54,517 |
| Aroa Biosurgery Incorporated | 29 | $22,613 |
| Integra Lifesciences Corporation | 5 | $8,830 |
| Wound Management Technologies, Inc | 4 | $6,184 |
| Kerecis Limited | 9 | $1,238 |
| Medline Industries LP | 6 | $655 |
| Acera Surgical, Inc. | 6 | $282 |
| TELA Bio, Inc. | 5 | $259 |
| TEI Biosciences Inc | 5 | $257 |
| Bone Support Inc. | 2 | $209 |
| Polynovo North America LLC | 3 | $204 |
| Mentor Worldwide LLC | 4 | $188 |
| Access Pro Medical, LLC | 1 | $165 |
| Organogenesis Inc. | 3 | $156 |
| Advanced Oxygen Therapy Inc. | 2 | $139 |
| Johnson & Johnson | 1 | $130 |
| Misonix Inc | 1 | $93 |
| Sanara Medtech Inc. | 2 | $84 |
| Mimedx Group, Inc. | 1 | $71 |
| OVIK Health, LLC | 1 | $51 |
| Tepha Inc | 1 | $47 |
| Sientra, Inc. | 2 | $40 |
| Hydrofera LLC | 2 | $38 |
| Medela LLC | 1 | $35 |
| Surgenex LLC | 1 | $29 |
| Reprise Biomedical, Inc. | 1 | $26 |
| Biom'up France SAS | 1 | $21 |
| Innovation Technologies Inc | 1 | $20 |
| Abbott | 1 | $17 |
| Polarityte, Inc. | 1 | $16 |
| Sonex Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- V.A.C. VERAFLO$282,636
- PREVENA$244,526
- PROMOGRAN PRISMA$180,526
- ACTIV.A.C.$164,808
- V.A.C. VERAFLO CLEANSE CHOICE$161,676
- V.A.C. DERMATAC$154,372
- 3M Cavilon$113,781
- VAC VERAFLO$103,124
- COLLAGENASE SANTYL$98,758
- V.A.C. ULTA$54,595
- PREVENA RESTOR BELLAFORM$50,346
- SNAP$47,153
- 3M Coban$45,833
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$43,509
- Oasis$31,913
- Santyl$30,578
- Bair Hugger$26,608
- KERRAMAX CARE$23,470
- RENASYS TOUCH$21,366
- Cavilon$21,239
How this compares
$2,217,403 in reported general payments places this provider in the 95th percentile of 63 plastic and reconstructive surgery providers in Arizona.
See all plastic and reconstructive surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $18,333 |
| Cephalexin | 15 | $179 |
| Ciprofloxacin Hcl | 30 | $125 |
| Tramadol Hcl | 13 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $176,062 | $18,33312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 63 plastic and reconstructive surgery providers in Arizona.
Other plastic and reconstructive surgery in Glendale
- Paul AngelchikGlendale$687
- Ha ChimPhoenix$355K
- Tamir MosharrafaPhoenix$210K
- Anthony AdmireTucson$85K
- Marc GottliebPhoenix$27K
- Joshua OlsonGilbert$22K
- Randall CraftPhoenix$20K
- Jinesh ShahPhoenix$14K
- Louis MillerYuma$13K
- Alvaro TestaGilbert$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.